QT
CLVS

Quantbot Technologies’s Clovis Oncology, Inc. CLVS Stock Holding History

Quantbot Technologies’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,590
Closed -$7K – 2046
2021
Q3 		$7K Sell
1,590
-445
-22% -$2.14K ﹤0.01% 1392
2021
Q2 		$11K Buy
+2,035
New +$11.9K ﹤0.01% 1299
2020
Q2 		– Sell
-23
Closed – – 1529
2020
Q1 		$0 Sell
23
-267
-92% -$2.14K ﹤0.01% 1541
2019
Q4 		$3K Sell
290
-2,410
-89% -$17.5K ﹤0.01% 1149
2019
Q3 		$10K Buy
2,700
+900
+50% +$7.28K ﹤0.01% 1170
2019
Q2 		$26K Buy
+1,800
New +$32.5K ﹤0.01% 1003
2018
Q2 		– Sell
-2,781
Closed -$146K – 1585
2018
Q1 		$146K Buy
+2,781
New +$162K 0.01% 761
2017
Q2 		– Sell
-2,913
Closed -$185K – 1468
2017
Q1 		$185K Buy
+2,913
New +$177K 0.02% 633
2016
Q4 		– Sell
-2,867
Closed -$103K – 1429
2016
Q3 		$103K Buy
+2,867
New +$61.5K 0.01% 723
2016
Q1 		– Sell
-1,252
Closed -$43K – 1480
2015
Q4 		$43K Buy
1,252
+72
+6% +$4.64K 0.01% 823
2015
Q3 		$108K Buy
+1,180
New +$102K 0.02% 739
2015
Q1 		– Sell
-1,070
Closed -$59K – 1426
2014
Q4 		$59K Buy
+1,070
New +$56.2K 0.02% 794
2014
Q3 		– Sell
-10,150
Closed -$420K – 1460
2014
Q2 		$420K Buy
10,150
+9,550
+1,592% +$492K 0.07% 389
2014
Q1 		$41K Buy
+600
New +$44.1K 0.01% 839

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantbot Technologies's CLVS Position: Q4 2021 in Review

Quantbot Technologies sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 1,590 shares — an estimated $7K sold.

Quantbot Technologies first reported a position in CLVS in Q1 2014 and held it in 14 quarters. The position peaked at $420K in Q2 2014. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Quantbot Technologies reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Quantbot Technologies sold 1,590 Clovis Oncology, Inc. shares in Q4 2021, an estimated $7K.
  • Quantbot Technologies first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 14 quarters.
  • Quantbot Technologies's Clovis Oncology, Inc. position peaked at $420K in Q2 2014.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.